Does cross-linking improve skin strength in Ehlers-Danlos syndrome?
Part of Blood & lymphatic, Genetic & congenital, Heart & circulation, Skin clinical trials.
This study tests whether a chemical cross-linking treatment can change the stretchiness and strength of skin in people with classic or hypermobile Ehlers-Danlos syndrome. Small skin samples will be taken to study the effects in the lab.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have been diagnosed with classic or hypermobile Ehlers-Danlos syndrome
- You are regularly seen at the EDS Reference Center at Garches Hospital in France
- You are not under legal protection (guardianship, etc.)
- You are not pregnant or breastfeeding
- You are covered by French social security and can give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects information about people with Ehlers-Danlos syndrome, including unborn babies diagnosed before birth. It may help researchers learn more about the condition and improve care over time.
This study uses an online questionnaire to explore how Ehlers-Danlos syndrome (EDS) may affect gynecological health. It compares women with EDS to those without, to better understand any differences.
This trial tests whether a non-invasive light therapy called photobiomodulation can reduce chronic pain and fatigue in people with hypermobile Ehlers-Danlos Syndrome (hEDS), a genetic condition affecting connective tissue. The light is applied to the skin and may help cells produce energy and reduce inflammation.
This study looks at skin cells and immune cells in people with systemic sclerosis to better understand what drives the disease. Your participation may help researchers learn how the immune system and skin support cells change over time.
This study looks at the immune system in people with recessive dystrophic epidermolysis bullosa (RDEB) and tests how placental stem cells affect immune cells in the lab. It aims to understand the disease better and explore potential treatments.
This study looks at how bodies with vascular Ehlers-Danlos syndrome (vEDS) process nutrients and energy differently. By comparing people with vEDS to healthy volunteers, researchers hope to find new ways to manage the condition better.
Hear when a new Ehlers-Danlos Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.